{{Use mdy dates|date=May 2020}}
{{short description|American physician}}
{{Infobox scientist
| name              = Esther Ellen Freeman
| alma_mater        = {{plain list|
*[[London School of Hygiene and Tropical Medicine]]
* [[Dartmouth College]]
*[[Harvard Medical School]]}}
| workplaces        = {{plain list|
*Harvard Medical School
*[[Massachusetts General Hospital]]}}
| thesis_title      = The role of herpes simplex virus Type 2 in the spread and control of HIV in four Sub-Saharan African Cities
| thesis_url        = http://www.worldcat.org/oclc/500303273
| thesis_year       = 2006
| birth_date        = {{Birth year and age|1979}}
}}

'''Esther Ellen Freeman''' (born 1979) is an American physician who is an Assistant Professor of Dermatology at the [[Harvard Medical School]] and Director of Global Health Dermatology at [[Massachusetts General Hospital]]. Her research considers [[HIV infection]] with AIDS-defining malignancies, including [[Kaposi's sarcoma]]. During the [[COVID-19 pandemic]] Freeman established the [[American Academy of Dermatology]] register of [[Covid-19|COVID-19]] skin complaints, through which she identified the novel symptom of [[Covid toes|COVID toes]].

== Early life and education ==
Freeman attended [[Milton Academy]].<ref name=":0">{{Cite web|title=Esther Freeman named 2002 Marshall Scholarship Winner|url=https://www.milton.edu/esther-freeman-97-named-2002-marshall-scholarship-winner/|last=|first=|date=December 6, 2001|website=Milton Academy|url-status=live|archive-url=|archive-date=|access-date=January 5, 2020}}</ref> As a child she was a competitive skier, and competed in the national championships at the age of twelve.<ref name=":0" /><ref>{{Cite web|title=FREEMAN Esther - Athlete Information|url=https://www.fis-ski.com/DB/general/athlete-biography.html?sector=FS&competitorid=18215&type=sum-WC|website=www.fis-ski.com|access-date=May 1, 2020}}</ref> By the age of fifteen Freeman was a member of the [[United States]] [[freestyle skiing]] team.<ref name=":0" /> Freeman earned her undergraduate degree at [[Dartmouth College]].<ref name=":0" /> Throughout her college career she skied in [[World Cup skiing|World Cup]] competitions and was a member of the Dartmouth sailing team.<ref name=":0" /> During her studies at Dartmouth Freeman spent time in [[Kenya]] and [[Mexico]]. In 2002 she was selected as a [[Marshall Scholarship|Marshall Scholar]], and moved to the [[United Kingdom]] to complete her graduate studies.<ref name=":0" /> She was a graduate student at the [[London School of Hygiene & Tropical Medicine]], where she studied [[HIV]] dermatology.<ref name="Freeman 2006">{{Cite book|last1=Freeman|first1=Esther|title=The role of herpes simplex virus Type 2 in the spread and control of HIV in four Sub-Saharan African Cities|last2=University of London|date=2006|publisher=University of London|location=London|language=English|oclc=500303273}}</ref> After completing her doctorate Freeman returned to the United States, where she started a medical degree at [[Harvard Medical School]], and soon after completed her specialist training in dermatology.{{citation needed|date=May 2020}}

== Research and career ==
In 2011 Freeman began work with the [[World Health Organization]], drafting guidelines on how to treat skin conditions that were associated with [[HIV]] in the [[developing world]].<ref>{{Cite web|title=Global Health Dermatology|url=https://www.massgeneral.org/dermatology/treatments-and-services/global-health-dermatology|website=Massachusetts General Hospital|language=en|access-date=May 1, 2020}}</ref>  For these efforts she was awarded the 2012 [[American Academy of Dermatology]] ''Members Making a Distance Award''.<ref>{{Cite web|title=Members Making a Difference Award|url=https://www.aad.org/member/career/awards/difference|website=www.aad.org|access-date=May 1, 2020}}</ref>

In 2013 Freeman was appointed Director of Global Health Dermatology at the [[Massachusetts General Hospital]]. Here she continued to investigate HIV dermatology, with a particular focus on [[Kaposi's sarcoma]].<ref>{{Cite web|title=2013 Award and Grant Recipients, American Skin Association|url=http://www.americanskin.org/research/recipients2013.php|last=|first=|date=|website=www.americanskin.org|url-status=live|archive-url=|archive-date=|access-date=May 1, 2020}}</ref> She serves on the leadership team of the International Alliance of Global Health Dermatology.<ref>{{Cite web|title=Introducing the International Alliance for Global Health Dermatology (GLODERM)|url=https://ilds.org/news/introducing-gloderm/|date=March 29, 2019|website=ILDS|language=en-GB|access-date=May 1, 2020}}</ref>

=== Leadership during the COVID-19 pandemic===
Freeman is a member of the American Academy of Dermatology task force on [[Coronavirus disease 2019|coronavirus disease]].<ref name=":1"/> As part of this effort, she launched and helped to compile a registry of skin complaints of [[Covid-19|COVID-19]] patients.<ref>{{Cite web|title=COVID-19 dermatology registry|url=https://www.aad.org/member/practice/coronavirus/registry|website=www.aad.org|access-date=May 1, 2020}}</ref><ref>{{Cite web|title='Frostbite' toes and other peculiar rashes may be signs of hidden coronavirus infection, especially in the young|url=https://www.seattletimes.com/nation-world/frostbite-toes-and-other-peculiar-rashes-may-be-signs-of-hidden-coronavirus-infection-especially-in-the-young/|date=April 29, 2020|website=The Seattle Times|language=en-US|access-date=May 1, 2020}}</ref><ref>{{Cite web|title=AAD Registry for Skin Manifestations of COVID-19: Q&A With Dr Freeman|url=https://www.the-dermatologist.com/article/aad-registry-skin-manifestations-covid-19-qa-dr-freeman|website=The Dermatologist|language=en|access-date=May 1, 2020}}</ref> Freeman had expected that coronavirus patients would present with [[viral rash]]es. By April 2020 it emerged that around half of the patients who presented with dermatological manifestations of coronavirus disease had so-called "[[Coronavirus disease|COVID]] toes".<ref name=":1">{{Cite web|title=Doctors find more cases of 'COVID toes' in dermatological registry. Here's what they learned.|url=https://www.usatoday.com/story/news/health/2020/04/27/coronavirus-doctors-learn-more-new-covid-19-symptom-covid-toes/3031743001/|last=Rodriguez|first=Adrianna|website=USA TODAY|language=en-US|access-date=May 1, 2020}}</ref> COVID toes are pinkish-reddish lesions that can turn purple as the coronavirus disease progresses (akin to [[pernio]] or [[chilblains]]),<ref>{{Cite web|title=Dermatology expert weighs in on 'COVID toes,' tracking dermatologic symptoms of COVID-19|url=https://www.healio.com/dermatology/dermatitis/news/online/%7B1f54025b-e860-4862-979d-46daebae6818%7D/dermatology-expert-weighs-in-on-covid-toes-tracking-dermatologic-symptoms-of-covid-19|date=April 24, 2020|website=www.healio.com|language=en|access-date=May 1, 2020}}</ref> but are distinct from ''[[purpura fulminans]]''.<ref name=":1" /><ref>{{Cite web|title='COVID toes' often appear in patients with no other symptoms|url=https://www.nbcnews.com/health/health-news/live-blog/2020-04-17-coronavirus-news-n1185971/ncrd1186676|last=UTC|first=A. Pawlowski14d ago / 11:16 PM|website=NBC News|language=en|access-date=May 1, 2020}}</ref> They typically last for two to three weeks and can without specific treatment.<ref>{{Cite web|title='Frostbite' toes, skin rashes may be sign of coronavirus|url=https://www.washingtonpost.com/health/2020/04/29/coronavirus-rashes-toes|last=|first=|date=April 29, 2020|website=|url-status=live|archive-url=|archive-date=|access-date=May 1, 2020}}</ref> The physiology behind COVID toes is not understood, but could occur due to inflammation of the toe tissue, inflammation of the blood vessel wall or small blood clots on the inside of the blood vessel.<ref name=":1" /><ref>{{Cite web|title=Are 'covid toes' a real symptom of the coronavirus?|url=https://www.foxnews.com/science/are-covid-toes-a-real-symptom-of-the-coronavirus|date=April 30, 2020|website=LiveScience|language=en-US|access-date=May 1, 2020}}</ref> Freeman has shown that even [[asymptomatic carrier]]s can present with COVID toes, and that most patients in the dermatological register with COVID toe are in their 20s and 30s.<ref name=":1" /> She has said that if people have these symptoms have no other cause to have such toes, they should try and get a [[COVID-19 testing|COVID-19 test]].<ref>{{Cite web|title='COVID toes' might be the latest unusual sign that people are infected with the novel coronavirus|url=https://www.businessinsider.com/covid-toes-frostbite-coronavirus-skin-lesion-discolored-swollen-feet-2020-4|last=Lee|first=Yeji Jesse|website=Business Insider|access-date=May 1, 2020}}</ref><ref name="Rabin">{{Cite news|last=Rabin|first=Roni Caryn|date=May 1, 2020|title=What Is 'Covid Toe'? Maybe a Strange Sign of Coronavirus Infection|language=en-US|work=The New York Times|url=https://www.nytimes.com/2020/05/01/health/coronavirus-covid-toe.html|access-date=May 1, 2020|issn=0362-4331}}</ref> [[Lindy Fox]], a dermatologist in [[San Francisco]], reported that despite it not being the right time of year for chilblains, she was seeing "clinics filled with people coming in with new toe lesions".<ref name="Rabin"/>

== Selected publications ==
*{{Cite paper|last1=Freeman|first1=Esther E|last2=Weiss|first2=Helen A|last3=Glynn|first3=Judith R|last4=Cross|first4=Pamela L|last5=Whitworth|first5=James A|last6=Hayes|first6=Richard J|date=2006|title=Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies|journal=AIDS|volume=20|issue=1|pages=73–83|doi=10.1097/01.aids.0000198081.09337.a7|pmid=16327322|s2cid=37946948|issn=0269-9370}}<ref>{{Cite journal|last1=Freeman|first1=Esther E|last2=Weiss|first2=Helen A|last3=Glynn|first3=Judith R|last4=Cross|first4=Pamela L|last5=Whitworth|first5=James A|last6=Hayes|first6=Richard J|date=2006|title=Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies|journal=AIDS|volume=20|issue=1|pages=73–83|doi=10.1097/01.aids.0000198081.09337.a7|pmid=16327322|s2cid=37946948|issn=0269-9370}}</ref>
*{{Cite paper|last1=Freeman|first1=Esther E.|last2=Orroth|first2=Kate K.|last3=White|first3=Richard G.|last4=Glynn|first4=Judith R.|last5=Bakker|first5=Roel|last6=Boily|first6=Marie-Claude|last7=Habbema|first7=Dik|last8=Buvé|first8=Anne|last9=Hayes|first9=Richard|date=August 1, 2007|title=Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics|url=https://sti.bmj.com/content/83/suppl_1/i17|journal=Sexually Transmitted Infections|language=en|volume=83|issue=suppl 1|pages=i17–i24|doi=10.1136/sti.2006.023549|issn=1368-4973|pmid=17405782|s2cid=30331411}}<ref>{{Cite journal|last1=Freeman|first1=Esther E.|last2=Orroth|first2=Kate K.|last3=White|first3=Richard G.|last4=Glynn|first4=Judith R.|last5=Bakker|first5=Roel|last6=Boily|first6=Marie-Claude|last7=Habbema|first7=Dik|last8=Buvé|first8=Anne|last9=Hayes|first9=Richard|date=August 1, 2007|title=Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics|url=https://sti.bmj.com/content/83/suppl_1/i17|journal=Sexually Transmitted Infections|language=en|volume=83|issue=suppl 1|pages=i17–i24|doi=10.1136/sti.2006.023549|issn=1368-4973|pmid=17405782|doi-access=free}}</ref>
*{{Cite document|author1=White, R. G. |author2=Glynn, J. R. |author3=Orroth, K. K. |author4=Freeman, E. E. |author5=Bakker, R. |author6=Weiss, H. A. |author7=Kumaranayake, L. |author8=Habbema, J. D. F. |author9=Buvé, A. |author10=Hayes, R. J.|date=2008|title=Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?|publisher=Lippincott, Williams & Wilkins|oclc=714926474}}<ref>{{Cite book|author1=White, R. G. |author2=Glynn, J. R. |author3=Orroth, K. K. |author4=Freeman, E. E. |author5=Bakker, R. |author6=Weiss, H. A. |author7=Kumaranayake, L. |author8=Habbema, J. D. F. |author9=Buvé, A. |author10=Hayes, R. J.|title=Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?|date=2008|publisher=Lippincott, Williams & Wilkins|oclc=714926474}}</ref>

== References ==
{{reflist}}

{{authority control}}

{{DEFAULTSORT:Freeman, Esther E.}}
[[Category:1979 births]]
[[Category:Living people]]
[[Category:American women physicians]]
[[Category:Women physicians]]
[[Category:Milton Academy alumni]]
[[Category:Dartmouth College alumni]]
[[Category:Harvard Medical School alumni]]
[[Category:Harvard Medical School faculty]]
[[Category:Massachusetts General Hospital faculty]]
[[Category:American dermatologists]]